NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Leif Carlsson
AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4399945
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Leif Carlsson's MOST POPULAR ARTICLES
1-)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional …WS Redfern, L Carlsson, AS Davis, WG Lynch, IL MacKenzie, ...Cardiovascular research 58 (1), 32-45, 200315362003
2-)
Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmicLM Hondeghem, L Carlsson, G DukerCirculation 103 (15), 2004-2013, 20015572001
3-)
Innovative approaches to anti-arrhythmic drug therapyS Nattel, L CarlssonNature reviews Drug discovery 5 (12), 1034-1049, 20062732006
4-)
QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventionsL Carlsson, O Almgren, G DukerJournal of cardiovascular pharmacology 16 (2), 276-285, 19902751990
5-)
Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisationsL Carlsson, C Abrahamsson, B Andersson, G Duker, G Schiller-LinhardtCardiovascular Research 27 (12), 2186-2193, 19932471993
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept